Papers in RSC Pharmaceutics
Page 6 · newest first
- Evaluation of drug release from polymeric nanoparticles in simulated saliva and gastric media by asymmetric flow field–flow fractionation (AF4)RSC Pharmaceutics · 2024
- Is receptor mediated active macrophage targeting of amphotericin B nanoformulations a promising approach?RSC Pharmaceutics · 2024
- Effect of leucine as an aerosolization enhancer on the bioactivity of spray dried viral-vectored vaccines for inhalationRSC Pharmaceutics · 2024
- Pharmaceutical salts of azole anti-fungal drugs: physicochemical behaviour and activity studiesRSC Pharmaceutics · 2024
- A pharmaco–technical investigation of oxaprozin and gaultheria oil nanoemulgel: a combination therapyRSC Pharmaceutics · 2024
- Biopharmaceutical advancement of efonidipine hydrochloride ethanolate through amorphous solid dispersion of a Parteck SLC mesoporous silica polymerRSC Pharmaceutics · 2024
- Thermodynamic and kinetic analysis of the melting process of S -ketoprofen and lidocaine mixturesRSC Pharmaceutics · 2024
- Increased thermal stability and retained antibacterial properties in a sulbactam and amantadine salt: towards effective antibacterial–antiviral combination therapiesRSC Pharmaceutics · 2024
- Biocompatible, injectable and self-healable MOF-based anti-freezing eutectogels for higher encapsulation and sustained release of the anticancer drug curcuminRSC Pharmaceutics · 2024
- In vitro anti-trypanosomal activity of 3-(aryl)-6-piperazin1,2,4-triazolo[3,4- a ]phthalazines-loaded ultrathin polymeric particles: effect of polymer type and particle sizeRSC Pharmaceutics · 2024
- A brief overview of quality by design approach for developing pharmaceutical liposomes as nano-sized parenteral drug delivery systemsRSC Pharmaceutics · 2024
- Effect of fluorine substituents in 4-(1-benzyl-1 H -benzo[ d ]imidazol-2-yl)thiazole for the study of antiparasitic treatment of cysticercosis on a Taenia crassiceps modelRSC Pharmaceutics · 2024
- Electrospun dressings with a dual release functionality of two anti-inflammatory active ingredientsRSC Pharmaceutics · 2024